Sofinnova Investments related stories
All articles and analysis
peHUB Wire: Friday, January 29, 2010The Teamsters Don't Know What They're Talking About
- peHUB Wire: Friday, January 29, 2010
The Teamsters Don't Know What They're Talking About
- The VC-Backed IPO Pipeline
There has been lots made /59667/vc-backed-ipos-up-ma-down-in-2009/ of the past year's anemic VC-backed IPO market, but let's leave the past behind and look at what could be coming up over the liquidity horizon. Our records indicate that there are 28 VC-backed companies currently in registration to price IPOs on U.S. exchanges, representing more than $3.75 billion in targeted raise. More than half of the registrations occured last quarter, but there's one from 2008 and even a pair from 2007. Also worth noting that for all the talk of 2010 being the year of the social network-related IPO (Facebook? LinkedIn? Zynga?), no such company is currently in registration. Closest we get are a pair of online marketing/advertising companies. Get the full lot of them after the jump...
Year in Review: IPOsThe VC-backed IPO market is improving, but it has a long way to go to get back to historical levels
- Durata Therapeutics Launches, Buys Virucon Pharma
Durata Therapeutics Inc., an antibiotic development platform recently formed by five venture capital firms, has acquired Vicuron Pharmaceuticals, developer of an antibiotic drug candidate called dalbavancin, from Pfizer. No financial terms were disclosed. Durata's backers are New Leaf Venture Partners, Domain Associates, Aisling Capital, Sofinnova Ventures and Canaan Partners.
IPO Acceleration PredictedInvestment banker says he has been deluged with calls from companies seeking to register to go public
- peHUB Wire: Monday, November 9, 2009
Random Ramblings
- peHUB Wire: Monday, November 9, 2009
Random Ramblings
- Week in deals, Oct. 26, 2009
Summary of North American tech companies and other startups that raised venture financing in the past week